Detection of silent myocardial ischemia in asymptomatic patients with diabetes: results of a randomized trial and meta-analysis assessing the effectiveness of systematic screening
2011

Screening for Silent Myocardial Ischemia in Diabetic Patients

Sample size: 631 publication Evidence: low

Author Information

Author(s): Lièvre Michel M, Moulin Philippe, Thivolet Charles, Rodier Michel, Rigalleau Vincent, Penfornis Alfred, Pradignac Alain, Ovize Michel

Primary Institution: Lyon 1 University

Hypothesis

Does screening asymptomatic diabetic patients for silent ischemia reduce cardiovascular events compared to usual care?

Conclusion

Systematic detection of silent ischemia in high-risk asymptomatic diabetic patients does not significantly improve outcomes compared to usual care.

Supporting Evidence

  • Follow-up was complete for 98.9% of patients regarding mortality.
  • Silent ischemia was detected in 21.5% of the screening group.
  • There was no significant difference in primary outcomes between the screening and usual care groups.

Takeaway

The study looked at whether checking for heart problems in people with diabetes who don't have symptoms helps them live longer or healthier. It found that it doesn't really make a difference.

Methodology

A randomized, open, blinded end-point multicenter trial with 3.5 years of follow-up in 631 diabetic patients across 45 hospitals.

Potential Biases

The open-label design may have influenced treatment decisions, although randomization was centralized.

Limitations

The study was stopped early due to recruitment difficulties and a lower-than-expected event rate, leading to insufficient power.

Participant Demographics

Patients were aged 63.9 ± 5.1 years, with diabetes and at least 2 additional cardiovascular risk factors.

Statistical Information

Confidence Interval

95%CI 0.59 to 1.71

Digital Object Identifier (DOI)

10.1186/1745-6215-12-23

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication